Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
Fundamentals
Mkt Cap
$573.69M
Volume
-
52W High
$15.50
52W Low
$8.63
PE Ratio
-
Avg. Volume
1.03M
EPS (Annual)
-$0.9874
P/B
-
Rev/Employee
-
Earnings
-
36
Bearish Sentiment
How do you feel about ETRA?
danielmaia12
If you like to enter those big runners before they go parabolic...
is a great bull to Follow - Made bank from his recent picks 💸🔥
Watching $ETRA $AIXI $SSM this morning
2
justiceforb_85
$ETRA significantly undervalued based on current MC based on the data presented for ipsoprubart in sHLH and the potential for treatment of T/NK cell lymphomas.
2
titanmaximum2
$ETRA I got shut out from Fidelity again on an IPO. This time I'm glad. I got in cheaper.
1
justiceforb_85
$ETRA ipsoprubart with compelling data in sHLH and outstanding data in T cell lymphoma. Starting a position.
1
AlertsAndNews
$ETRA new IPO tomorrow
Electra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public Offering
"today announced the pricing of its upsized initial public offering of 23,333,334 shares of common stock at a price to the public of $15.00 per share"